Lesson of the month 1: Septic arthritis with normal acute phase reactants and white cell count in a patient receiving tocilizumab
Related Experiment Video
Updated: Mar 1, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Richard Conway1, Carl Orr2, Geraldine M McCarthy2
1Mater Misericordiae University Hospital and CARD Newman Research Fellow, University College Dublin, Dublin, Ireland drrichardconway@gmail.com.
Abstract:
Septic arthritis represents 8-27% of cases of monoarthritis presenting to the emergency department. Tocilizumab is an interleukin-6 blocking monoclonal antibody with the mechanistic potential to interfere with the body's normal inflammatory response to an infectious insult. We present a case of septic arthritis with a normal white cell count, C-reactive protein, erythrocyte sedimentation rate and fibrinogen in a patient treated with tocilizumab.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Acute Pyelonephritis II: Diagnostic Studies and Management
Inflammatory Response I: Vascular and Cellular
Pericarditis I: Introduction
Acute Pyelonephritis I: Introduction

